Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin R Green

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Seminars in Cell & Developmental Biology|December 22, 2015
Translating connexin biology into therapeuticsDavid L Becker, Anthony R Phillips, Bradford J Duft, et al.
Drug Delivery|June 24, 2011
In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotidesYing-Shan Chen, Raid G Alany, Simon A Young, et al.
Progress in Retinal and Eye Research|October 4, 2015
Connexin43 in retinal injury and diseaseHelen V Danesh-Meyer, Jie Zhang, Monica L Acosta, et al.
Journal of Biomolecular Techniques : JBT|October 10, 2006
In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene familyLee Yong Law, Wei V Zhang, N Susan Stott, et al.
The International Journal of Neuroscience|October 15, 2010
Effect of low Mg2+ and bicuculline on cell survival in hippocampal slice culturesJinny J Yoon, Colin R Green, Ji-Zhong Bai, et al.
Expert Opinion on Therapeutic Targets|September 27, 2019
Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye diseaseOdunayo O Mugisho, Ilva D Rupenthal, Francois Paquet-Durand, et al.
International Journal of Molecular Sciences|July 4, 2012
Deleterious effects of high dose connexin 43 mimetic peptide infusion after cerebral ischaemia in near-term fetal sheepJoanne O Davidson, Colin R Green, Louise F B Nicholson, et al.
Neuroscience Research|February 14, 2013
Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injurySimon J O'Carroll, Catherine A Gorrie, Sailakshmi Velamoor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 16, 2014
Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemiaYing-Shan Chen, Colin R Green, Kailun Wang, et al.
Journal of Pharmaceutical Sciences|May 23, 2013
Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathyYing-Shan Chen, Istvan Toth, Helen V Danesh-Meyer, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Seminars in Cell & Developmental Biology|December 22, 2015
Translating connexin biology into therapeuticsDavid L Becker, Anthony R Phillips, Bradford J Duft, et al.
Drug Delivery|June 24, 2011
In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotidesYing-Shan Chen, Raid G Alany, Simon A Young, et al.
Progress in Retinal and Eye Research|October 4, 2015
Connexin43 in retinal injury and diseaseHelen V Danesh-Meyer, Jie Zhang, Monica L Acosta, et al.
Journal of Biomolecular Techniques : JBT|October 10, 2006
In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene familyLee Yong Law, Wei V Zhang, N Susan Stott, et al.
The International Journal of Neuroscience|October 15, 2010
Effect of low Mg2+ and bicuculline on cell survival in hippocampal slice culturesJinny J Yoon, Colin R Green, Ji-Zhong Bai, et al.
Expert Opinion on Therapeutic Targets|September 27, 2019
Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye diseaseOdunayo O Mugisho, Ilva D Rupenthal, Francois Paquet-Durand, et al.
International Journal of Molecular Sciences|July 4, 2012
Deleterious effects of high dose connexin 43 mimetic peptide infusion after cerebral ischaemia in near-term fetal sheepJoanne O Davidson, Colin R Green, Louise F B Nicholson, et al.
Neuroscience Research|February 14, 2013
Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injurySimon J O'Carroll, Catherine A Gorrie, Sailakshmi Velamoor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 16, 2014
Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemiaYing-Shan Chen, Colin R Green, Kailun Wang, et al.
Journal of Pharmaceutical Sciences|May 23, 2013
Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathyYing-Shan Chen, Istvan Toth, Helen V Danesh-Meyer, et al.
Pageof 12